{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T05:40:28Z","timestamp":1791265228078,"version":"4.1.0"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.jcrs.2008.05.034","type":"journal-article","created":{"date-parts":[[2008,8,21]],"date-time":"2008-08-21T09:17:06Z","timestamp":1219310226000},"page":"1451-1459","source":"Crossref","is-referenced-by-count":97,"title":["Evaluation of the safety of prophylactic intracameral moxifloxacin in cataract surgery"],"prefix":"10.1097","volume":"34","author":[{"given":"Stephen S.","family":"Lane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert H.","family":"Osher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Masket","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaleen","family":"Belani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-17-20210210","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jcrs.2006.02.021","article-title":"ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery; preliminary report of principal results from a European multicenter study; the ESCRS Endophthalmitis Study Group.","volume":"32","author":"Barry","year":"2006","journal-title":"J Cataract Refract Surg"},{"key":"R2-17-20210210","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.jcrs.2007.02.032","article-title":"Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors.","volume":"33","year":"2007","journal-title":"J Cataract Refract Surg"},{"key":"R3-17-20210210","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/S0886-3350(01)01269-X","article-title":"Prophylactic intracameral cefuroxime; efficacy in preventing endophthalmitis after cataract surgery.","volume":"28","author":"Montan","year":"2002","journal-title":"J Cataract Refract Surg"},{"key":"R4-17-20210210","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/S0886-3350(01)01270-6","article-title":"Prophylactic intracameral cefuroxime; evaluation of safety and kinetics in cataract surgery.","volume":"28","author":"Montan","year":"2002","journal-title":"J Cataract Refract Surg"},{"issue":"suppl","key":"R5-17-20210210","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.survophthal.2005.06.002","article-title":"In vitro and in vivo potency of moxifloxacin and moxifloxacin ophthalmic solution 0.5, a new topical fluoroquinolone.","volume":"50","author":"Stroman","year":"2005","journal-title":"Surv Ophthalmol"},{"key":"R6-17-20210210","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S0002-9394(03)00294-0","article-title":"Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates.","volume":"136","author":"Kowalski","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"R7-17-20210210","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1016\/j.ophtha.2005.06.025","article-title":"An ophthalmologists guide to understanding antibiotic susceptibility and minimum inhibitory concentration data.","volume":"112","author":"Kowalski","year":"2005","journal-title":"Ophthalmology"},{"key":"R8-17-20210210","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0002-9394(02)01334-X","article-title":"Fourth generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibiotics.","volume":"133","author":"Mather","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"R9-17-20210210","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1001\/archopht.1977.04450120124018","article-title":"Rabbit endothelial response to ophthalmic preservatives.","volume":"95","author":"Green","year":"1977","journal-title":"Arch Ophthalmol"},{"key":"R10-17-20210210","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1016\/S0886-3350(01)01067-7","article-title":"Toxic endothelial cell destruction from intraocular benzalkonium chloride.","volume":"27","author":"Liu","year":"2001","journal-title":"J Cataract Refract Surg"},{"key":"R12-17-20210210","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/S0886-3350(97)80081-8","article-title":"Anterior chamber contamination during cataract surgery with intraocular lens implantation.","volume":"23","author":"Mistlberger","year":"1997","journal-title":"J Cataract Refract Surg"},{"key":"R14-17-20210210","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S0002-9394(14)76728-5","article-title":"Anterior chamber aspirate cultures after uncomplicated cataract surgery.","volume":"112","author":"Dickey","year":"1991","journal-title":"Am J Ophthalmol"},{"key":"R15-17-20210210","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/sj.eye.6701899","article-title":"Influence of age on conjunctival bacteria of patients undergoing cataract surgery.","volume":"20","author":"Rubio","year":"2006","journal-title":"Eye"},{"key":"R20-17-20210210","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.icl.0000246872.73559.43","article-title":"Comparative minimal inhibitory and mutant prevention drug concentrations of four fluoroquinolones against ocular isolates of Haemophilus influenzae.","volume":"33","author":"Hedlin","year":"2007","journal-title":"Eye Contact Lens"},{"key":"R22-17-20210210","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ijantimicag.2004.02.021","article-title":"Comparison of minimal inhibitory and mutant prevention drug concentrations of 4 fluoroquinolones against clinical isolates of methicillin-susceptible and -resistant Staphylococcus aureus.","volume":"24","author":"Metzler","year":"2004","journal-title":"Int J Antimicrob Agents"},{"key":"R24-17-20210210","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.ophtha.2006.01.061","article-title":"Fourth-generation fluoroquinolone penetration into the aqueous humor in humans.","volume":"113","author":"McCulley","year":"2006","journal-title":"Ophthalmology"},{"key":"R25-17-20210210","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.ophtha.2004.09.029","article-title":"Penetration of topically applied gatifloxacin 0.3, moxifloxacin 0.5 and ciprofloxacin 0.3 into the aqueous humor.","volume":"112","author":"Solomon","year":"2005","journal-title":"Ophthalmology"},{"key":"R26-17-20210210","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jcrs.2006.09.015","article-title":"Aqueous humor penetration of gatifloxacin and moxifloxacin in eyedrops given by different methods before cataract surgery.","volume":"33","author":"Ong-Tone","year":"2007","journal-title":"J Cataract Refract Surg"},{"key":"R27-17-20210210","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1097\/01.ico.0000157423.78275.a2","article-title":"Absorption of topical moxifloxacin ophthalmic solution into human aqueous humor.","volume":"24","author":"Katz","year":"2005","journal-title":"Cornea"},{"key":"R28-17-20210210","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1016\/j.ophtha.2005.06.017","article-title":"Aqueous penetration and biological activity of moxifloxacin 0.5 ophthalmic solution and gatifloxacin 0.3 solution in cataract surgery patients.","volume":"112","author":"Kim","year":"2005","journal-title":"Ophthalmology"},{"key":"R29-17-20210210","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1001\/archopht.123.1.39","article-title":"Penetration pharmacokinetics of topically administered 0.5 moxifloxacin ophthalmic solution in human aqueous and vitreous.","volume":"123","author":"Hariprasad","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"R30-17-20210210","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ajo.2007.03.036","article-title":"Differential aqueous and vitreous concentrations of moxifloxacin and ofloxacin after topical administration one hour before vitrectomy.","volume":"144","author":"Lai","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"R31-17-20210210","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/0002-9394(74)90016-6","article-title":"Cytotoxicity of ophthalmic preservatives.","volume":"78","author":"Gasset","year":"1974","journal-title":"Am J Ophthalmol"},{"key":"R32-17-20210210","first-page":"395","article-title":"Cytotoxic effects of benzalkonium chloride and chorobutanol on human corneal epithelial cells in vitro.","volume":"6","author":"Tripathi","year":"1989","journal-title":"Lens Eye Toxic Res"},{"issue":"suppl 1","key":"R33-17-20210210","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1016\/j.survophthal.2005.05.003","article-title":"Safety of moxifloxacin as shown in animal and in vitro studies.","volume":"50","author":"McGee","year":"2005","journal-title":"Surv Ophthalmol"},{"key":"R34-17-20210210","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1097\/01.ico.0000220777.70981.46","article-title":"Efficacy and safety of moxifloxacin as an additive in Optisol-GS a preservation medium for corneal donor tissue.","volume":"25","author":"Ritterband","year":"2006","journal-title":"Cornea"},{"key":"R36-17-20210210","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1097\/IAE.0b013e3181733733","article-title":"Pegaptanib combined with intravitreal injection of moxifloxacin as treatment of wet macular degeneration.","volume":"28","author":"Bennett","year":"2008","journal-title":"Retina"},{"issue":"suppl 2","key":"R37-17-20210210","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s15010-005-8209-8","article-title":"Immunomodulatory activities of fluoroquinolones.","volume":"33","author":"Dalhoff","year":"2005","journal-title":"Infection"},{"key":"R41-17-20210210","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.ajo.2005.04.015","article-title":"Intracameral Vigamox (moxifloxacin 0.5) is non-toxic and effective in preventing endophthalmitis in a rabbit model.","volume":"140","author":"Kowalski","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"R42-17-20210210","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jcrs.2006.09.019","article-title":"Safety of prophylactic intracameral moxifloxacin 0.5 ophthalmic solution in cataract surgery patients.","volume":"33","author":"Espiritu","year":"2007","journal-title":"J Cataract Refract Surg"},{"key":"R43-17-20210210","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1016\/j.jcrs.2007.06.026","article-title":"Perspectives on antibiotics for postoperative endophthalmitis prophylaxis: potential role of moxifloxacin.","volume":"33","author":"OBrien","year":"2007","journal-title":"J Cataract Refract Surg"},{"key":"R44-17-20210210","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.jcrs.2008.03.017","article-title":"Safety of intracameral moxifloxacin for prophylaxis of endophthalmitis after cataract surgery.","volume":"34","author":"Arbisser","year":"2008","journal-title":"J Cataract Refract Surg"}],"container-title":["Journal of Cataract and Refractive Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0886335008006305?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0886335008006305?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ovid.com\/10.1016\/j.jcrs.2008.05.034","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:14:21Z","timestamp":1786036461000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/02158034-200809000-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1016\/j.jcrs.2008.05.034","relation":{},"ISSN":["0886-3350"],"issn-type":[{"value":"0886-3350","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}